Table 3 Asymmetric cascade sulfa-Michael–aldol reaction of 1 with
b-aryl substituted a,b-unsaturated N-pyrazole-derived amide (2)a
various a,b-unsaturated N-acylimide bearing pyrazole moieties,
which provided H-bond acceptor sites for better chelation and
asymmetric induction, leading to excellent diastereoselectivity and
enantioselectivity for both b-aryl and b-alkyl a,b-unsaturated
N-acylimide.
This work was supported by NSFC (20972117, 21172176),
IRT1030, NCET-10-0649, the Fundamental Research Funds
for the Central Universities, 973 (2011CB808600), and Large-
scale instrument and equipment sharing foundation of Wuhan
University.
Entry
Ar
4
Yieldb (%)
drc
eec,d (%)
1
2
3
4
5
6
7
8
Ph (2i)
3i
3j
3k
3l
3m
3n
3o
3p
3q
3r
3s
87
85
88
89
86
90
92
90
94
87
91
99 : 1
98 : 2
97 : 3
98 : 2
97 : 3
97 : 3
95 : 5
98 : 2
98 : 2
97 : 3
95 : 5
99
99
99
98
97
97
98
99
97
99
95
o-Me-Ph (2j)
m-Me-Ph (2k)
p-Me-Ph (2l)
p-MeO-Ph (2m)
o-Cl-Ph (2n)
m-Cl-Ph (2o)
p-Cl-Ph (2p)
p-Br-Ph (2q)
2-Naphthyl (2r)
2-Furyl (2s)
Notes and references
1 (a) A. Nudelman, The Chemistry of Optically Active Sulfur Compounds,
New York, 1984; (b) Sulphur-Containing Drugs and Related Organic
Compounds, ed. L. A. Damani, Wiley, New York, 1989; (c) Chiral
Sulfur Ligands: Asymmetric Catalysis, ed. H. Pellissier, Cambridge,
UK, 2009; (d) Y.-L. Shi and M. Shi, Org. Biomol. Chem., 2007, 5, 1499.
2 E. E. Schweizer and O. Meeder-Nycz, in Chromenes, Chromanes,
Chromones, ed. G. P. Ellis, Wiley-Interscience, New York, 1977.
3 (a) T. Yoneya, K. Taniguchi, R. Nakamura, T. Tsunenari, I. Ohizumi,
Y. Kanbe, K. Morikawa, S.-I. Kaiho and H. Yamada-Okabe,
Anticancer Res., 2010, 30, 873; (b) Y. Kanbe, M.-H. Kim,
M. Nishimoto, Y. Ohtake, T. Tsunenari, K. Taniguchi,
I. Ohizumi, S.-I. Kaiho, Y. Nabuchi, S. Kawata, K. Morikawa,
J.-C. Jo, H.-A. Kwon, H.-S. Lim and H.-Y. Kim, Bioorg. Med.
Chem. Lett., 2006, 16, 4090.
9
10
11
a
All the reactions were carried out with 0.3 mmol of 1, 0.33 mmol of
b
2 in 1.0 mL of solvent. Isolated yield. Determined by HPLC
d
analysis. The absolute configuration of 3r was unequivocally deter-
mined to be (2S,3R,4S) by X-ray crystallographic analysis (see ESI).
c
4 Y. Chen, Q. Zhang, B. Zhang, P. Xia, Y. Xia, Z.-Y. Yang,
N. Kilgore, C. Wild, S. L. Morris-Natschka and K.-H. Lee, Bioorg.
Med. Chem., 2004, 12, 6383.
5 L. A. V. Vliet, N. Rodenhuis, D. Dijkstra, H. Wikstrom,
T. A. Pugsley, K. A. Serpa, L. T. Meltzer, T. G. Heffner,
L. D. Wise, M. E. Lajiness, R. M. Huff, K. Svensson, S. Sundell
and M. Lundmark, J. Med. Chem., 2000, 43, 2871.
Scheme 1 Synthetic transformation of the sulfa-Michael–aldol adduct 3a.
6 (a) L. Zimmer, G. Fournet, B. Joseph, G. Guillaumet and D. L. Bars,
Nucl. Med. Biol., 2003, 30, 541; (b) M. E. Castro, P. J. Harrison,
A. Pazos and T. Sharp, J. Neurochem., 2000, 75, 755.
7 (a) W. Wang, H. Li, J. Wang and L. Zu, J. Am. Chem. Soc., 2006,
128, 10354; (b) L. Zu, J. Wang, H. Li, H. Xie, W. Jiang and W. Wang,
J. Am. Chem. Soc., 2007, 129, 1036; (c) R. Rios, H. Sunden,
I. Ibrahem, G.-L. Zhao and A. Cordova, Tetrahedron Lett., 2006,
´
47, 8679; (d) R. Dodda, J. J. Goldman, T. Mandal, C.-G. Zhao,
G. A. Broker and E. R. T. Tiekink, Adv. Synth. Catal., 2008, 350, 537.
8 X.-Q. Dong, X. Fang and C.-J. Wang, Adv. Synth. Catal., 2012,
354, 1141.
9 X.-Q. Dong, X. Fang and C.-J. Wang, Org. Lett., 2011, 13, 4426.
10 (a) M. P. Sibi and K. Itoh, J. Am. Chem. Soc., 2007, 129, 8064;
(b) K. Ishihara and M. Fushimi, Org. Lett., 2006, 8, 1921.
11 For reviews on bifunctional organocatalysis, see: (a) S. B. Tsogoeva,
Eur. J. Org. Chem., 2007, 1701; (b) T. Marcelli, J. H. V. Maarseveen
and H. Hiemstra, Angew. Chem., Int. Ed., 2006, 45, 7496; (c) S. J.
Connon, Chem.–Eur. J., 2006, 12, 5418.
12 For recent examples of thiourea-catalyzed reactions, see: (a) Q. Gu
and S.-L. You, Chem. Sci., 2011, 2, 1519; (b) B. Han, Q.-P. Liu,
R. Li, X. Tian, X.-F. Xiong, J.-G. Deng and Y.-C. Chen,
Chem.–Eur. J., 2008, 14, 8094; (c) D. Zhao, D. Yang, Y. Wang,
Y. Wang, L. Wang, L. Mao and R. Wang, Chem. Sci., 2011,
2, 1918; (d) Y. Cao, X. Jiang, L. Liu, F. Shen, F. Zhang and
R. Wang, Angew. Chem., Int. Ed., 2011, 50, 9124; (e) Y. Liu,
B. Sun, B. Wang, M. Wakem and L. Deng, J. Am. Chem. Soc.,
2009, 131, 418; (f) W. Li, W. Wu, F. Yu, H. Huang, X. Liang and
J. Ye, Org. Biomol. Chem., 2011, 9, 2505; (g) Y.-H. Liao, X.-L. Liu,
Z.-J. Wu, X.-L. Du, X.-M. Zhang and W.-C. Yuan, Adv. Synth.
Catal., 2012, 353, 1720; (h) F. Wang, X. Liu, X. Cui, Y. Xiong,
X. Zhou and X. Feng, Chem.–Eur. J., 2009, 15, 589.
Scheme 2 Control experiments to evaluate the role of the amide moiety
under the optimized reaction conditions (pyrazole vs. oxazolidineone).
moiety14 and then esterification without loss of diastereo/
enantiomeric excess.
In order to evaluate the role of the pyrazole motif played in
this domino sulfa-Michael–aldol reaction, control experiments
were carried out under the optimized reaction conditions
(Scheme 2): for a,b-unsaturated N-acylimide bearing methyl
at the b-position, replacing the oxazolidineone group with the
pyrazole group led to a superior level of enantioselectivity and
diastereoselectivity with the same sense of diastereoselectivity,
which demonstrated that introducing the pyrazole moiety into
the crotonamide plays a significant role in providing H-bond
acceptor sites for better organization and chelation and hence
delivering higher enantioselectivity compared with that of
employing oxazolidineone as the corresponding amide moiety.
In summary, we have developed an efficient protocol for the
direct construction of highly substituted and biologically active
thiochromanes via an organocatalyzed asymmetric cascade
sulfa-Michael–aldol reaction of 2-mercaptobenzaldehyde with
13 (a) C.-J. Wang, Z.-H. Zhang, X.-Q. Dong and X.-J. Wu, Chem.
Commun., 2008, 1431; (b) C.-J. Wang, X.-Q. Dong, Z.-H. Zhang,
Z.-Y. Xue and H.-L. Teng, J. Am. Chem. Soc., 2008, 130, 8606;
(c) X.-Q. Dong, H.-L. Teng, M.-C. Tong, H. Huang, H.-Y. Tao
and C.-J. Wang, Chem. Commun., 2010, 46, 6840.
14 A. B. Smith III, T. Bosanac and K. Basu, J. Am. Chem. Soc., 2009,
131, 2348.
c
7240 Chem. Commun., 2012, 48, 7238–7240
This journal is The Royal Society of Chemistry 2012